DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at BidaskClub

BidaskClub upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a sell rating to a hold rating in a research note issued to investors on Tuesday, BidAskClub reports.

Several other equities research analysts also recently commented on the stock. Wellington Shields upgraded shares of DENTSPLY SIRONA from a hold rating to a gradually accumulate rating in a research note on Friday, August 2nd. HC Wainwright restated a neutral rating and issued a $57.00 target price (up previously from $55.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, July 9th. Barrington Research restated a buy rating and issued a $63.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. Evercore ISI began coverage on shares of DENTSPLY SIRONA in a research report on Friday, July 26th. They set an in-line rating on the stock. Finally, ValuEngine downgraded shares of DENTSPLY SIRONA from a hold rating to a sell rating in a research report on Wednesday, October 2nd. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus price target of $54.57.

Shares of NASDAQ:XRAY opened at $54.11 on Tuesday. DENTSPLY SIRONA has a 52 week low of $33.93 and a 52 week high of $59.40. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08. The company’s fifty day moving average is $52.12 and its 200-day moving average is $53.55. The company has a market capitalization of $12.13 billion, a PE ratio of 26.92, a P/E/G ratio of 1.92 and a beta of 0.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Friday, August 2nd. The medical instruments supplier reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.04. DENTSPLY SIRONA had a net margin of 2.67% and a return on equity of 9.19%. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter in the previous year, the company earned $0.60 EPS. The firm’s revenue for the quarter was down 3.1% compared to the same quarter last year. On average, analysts forecast that DENTSPLY SIRONA will post 2.39 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were given a dividend of $0.10 per share. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. The ex-dividend date of this dividend was Thursday, September 26th. This represents a $0.40 annualized dividend and a yield of 0.74%. DENTSPLY SIRONA’s dividend payout ratio is 19.90%.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Altshuler Shaham Ltd lifted its position in DENTSPLY SIRONA by 209.8% during the 2nd quarter. Altshuler Shaham Ltd now owns 505 shares of the medical instruments supplier’s stock worth $30,000 after buying an additional 342 shares in the last quarter. Cornerstone Advisors Inc. raised its holdings in DENTSPLY SIRONA by 62.0% during the 2nd quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock worth $53,000 after purchasing an additional 346 shares during the last quarter. Van ECK Associates Corp bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth about $54,000. Arcadia Investment Management Corp MI bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth about $58,000. Finally, Hanseatic Management Services Inc. raised its holdings in DENTSPLY SIRONA by 70.8% during the 2nd quarter. Hanseatic Management Services Inc. now owns 1,030 shares of the medical instruments supplier’s stock worth $60,000 after purchasing an additional 427 shares during the last quarter. Institutional investors and hedge funds own 94.67% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: Investing in Blue-Chip Stocks

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.